Exciting new results from our lab identifying a new driver and therapeutic target for highly aggressive metastatic prostate cancer with neuroendocrine features are published in PNAS. Congratulations En-Chi!
Exciting new results from our lab identifying a new driver and therapeutic target for highly aggressive metastatic prostate cancer with neuroendocrine features are published in PNAS. Congratulations En-Chi!